CAR T-Cell Trials in DLBCL, FL Reflect Continued Promise
Updated results from the JULIET trial, testing tisagenlecleucel (Kymriah) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL), revealed encouraging long term results.
Research News
Lymphoma Research Foundation Grantee, Scientific Advisory Board Chair Lead International Commission on Adverse Events in the Treatment of Lymphoma
As novel treatments have increased survival rates and changed treatment paradigms for lymphoma, the need to better understand the side effects of these new treatments on patients has been magnified. Some types of lymphoma are now treated with continuous pill…
LRF Announces Research Grants in Mantle Cell Lymphoma, Lymphoma Clinical Research Mentoring Program
In conjunction with the Mantle Cell Lymphoma Scientific Workshop, the Lymphoma Research Foundation announced two MCL Therapeutic Studies Grants, awarded to Sandeep Dave, MD, MS of Duke University and Jianguo Tao, MD of H. Lee Moffitt Cancer Center. As…
Lymphoma Research Foundation Adherence in Oral Therapies Scientific Meeting Featured in ASCO Post
The Lymphoma Research Foundation (LRF) is pleased to announce that scientific proceedings and priorities from LRF’s Adherence in Oral Therapies Scientific Meeting has been published in the prestigious scientific journal, The ASCO Post. As co-chairs of both of LRF’s scientific…
Lymphoma Research Foundation Publishes White Paper Outlining Adherence and Oral Therapies in Lymphoma and CLL
Lymphoma Research Foundation Publishes White Paper to Outline Key Issues Discussed During Second Oral Therapies Workshop In October 2017, The Lymphoma Research Foundation (LRF) convened its second Adherence and Oral Therapies in Lymphoma and CLL Workshop with a diverse faculty to…
LRF Scientific Workshop Examines Adherence and Oral Therapies in Lymphoma and CLL
Oral medications are being increasingly used to treat patients with lymphoma and chronic lymphocytic leukemia (CLL). Five oral drugs have been approved over the past three years for eight different indications in lymphoma and CLL. Many patients report numerous advantages…
Lymphoma Research Foundation Showcases Record Number of Researchers at 2017 American Society of Hematology Annual Meeting
LRF Scientific Advisory Board Members to be Joined by Current and Former Grantees at the 59th ASH Annual Meeting & Exposition New York, NY (December 7, 2017) –The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively…
LRF Publishes Recommendations on Adolescent and Young Adult Lymphoma Research
Findings from the 2015 Lymphoma Research Foundation scientific symposium on adolescent/young adult (AYA) lymphomas have been published int he influential journal Blood Advances. The paper, “Adolescent and Young Adult Lymphoma: Collaborative Efforts at Understanding Biology and Optimizing Care,” reviews lymphoma…
Lymphoma Research Foundation Makes Additional $700,000 Investment in Young Investigators
The Lymphoma Research Foundation announced the recipients of its 2017 Postdoctoral Fellowship Grants, representing more than $700,000 in additional funding for leading lymphoma researchers in the first five years of their careers.
Lymphoma Research Foundation Announces Scientific Advisory Board Chair Thomas M. Habermann for FY 2018-2019
The Nation’s Premier Lymphoma-Specific Research Organization Also Adds Four Experts to Industry Leading SAB New York, NY (July 1, 2017) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…